The company predicted a full-year impact of 200 million to 250 million euros, down from its previous forecast of up to 300 ...

This earnings season, top medical device companies have dramatically reduced their expectations for tariff impacts in 2025.

Venture capital investment across the healthcare sector slowed in the first half of the year, but investors are spending on ...

Executives at the laboratory companies said they expect the effects on testing services from the Republicans’ tax and ...

The company previously forecast an up to 300 million euro tariff impact in 2025 before the U.S. struck agreements with China ...

Johnson & Johnson’s Ethicon unit has corrected disposable surgical stapler cartridges over a fault related to one death and one injury, the Food and Drug Administration said Friday.

Olympus and Revival Healthcare Capital agreed to invest up to $458 million combined to co-found a company that will develop a ...

Most imports from the bloc would face a 15% tariff under the pact, U.S. President Donald Trump and European Commission ...

To lead in this era, medtech companies must expand how they innovate — combining scientific rigor with human connection, ...

Exposed wires could puncture the artery and cause bleeding, inadequate perfusion and hemolysis, the FDA said in its Class I ...

The renewed strength in TAVR, following a slowdown last year tied to heart team capacity challenges at hospitals, prompted ...

The European Commission plans to install duties of up to 30%, starting Aug. 7, if the bloc cannot reach a deal with the U.S.